ExpreS2ion Biotech Holding AB Financial Overview
ExpreS2ion Biotech Holding AB's market cap is currently kr59.73M. The company's EPS TTM is kr-3.177; its P/E ratio is -0.93; ExpreS2ion Biotech Holding AB is scheduled to report earnings on November 13, 2025, and the estimated EPS forecast is kr―. See an overview of income statement, balance sheet, and cash flow financials.
